menu toggle

Industry partnerships

To strengthen the pharmaceutical supply chain and maximize our impact, we collaborate with government entities, like-minded organizations and nonprofits committed to reducing drug shortages and mitigating disruptions to the supply chain.


Strategic trade and industry collaborations

We continue to work with other stakeholders as a thought leader to develop public policy solutions that promote a resilient drug supply chain.

Healthcare Distribution Alliance

We are members of the Healthcare Distribution Alliance (HDA), a national organization that represents pharmaceutical distributors. HDA advocates for policies and solutions to address critical issues in the pharmaceutical supply chain, including drug shortages and healthcare access.

 

 

Duke-Margolis ReVAMP Drug Supply Chain Consortium

We are a founding member of the Duke-Margolis Drug Supply Chain Resilience and Advanced Manufacturing Consortium—a diverse group of stakeholders formally established in 2023, working together to identify effective policy solutions for a resilient drug supply chain with advanced manufacturing capabilities to reduce the frequency and severity of drug shortages. The consortium consists of health care companies, trade associations, and government observers, including ASPE, ASPR and the FDA.

Securing America’s Medicines and Supply (SAMS)

We are a member  of Securing America’s Medicines and Supply (SAMS), a coalition of companies to strengthen the security of the medical supply chain in the United States. SAMS seeks legislation and regulation to reward and foster U.S.-made manufacturing of important pharmaceutical products, devices, and PPE.

Healthcare Leadership Council (HLC)

We are also a member of the Healthcare Leadership Council (HLC), a coalition of chief executives from all disciplines within American healthcare.

End Drug Shortages Alliance (EDSA)

Since 2022, we have been a proud member of the End Drug Shortages Alliance (EDSA). First established in December 2021, the EDSA is a non-profit collective of 80+ organizations on a mission to end drug shortages through a focus on transparency, quality, redundancy, and production of additional supply to achieve measured and sustainable results.

Public-private partnerships

Cencora also helps strengthen the drug supply chain and address drug shortages through public-private partnerships.

Essential Med Reserve

Cencora provides a virtual solution for managing drug stockpiles, eliminating outdated and cumbersome physical reserves. Our platform offers up-to-date and easily deployable essential medications through a robust supply chain. By integrating precise planning, strategic medication reserves in our warehouses, and rapid activation procedures within our distribution network, we cater to the unique needs of U.S. State governments, ensuring access to critical medicines during crises and emergencies.

CivicaRx

In 2023, Cencora entered a partnership with CivicaRx, a nonprofit generic drug company founded in 2018 by national philanthropies and leading U.S. health systems. CivicaRx’s mission is to reduce and prevent drug shortages in the United States and accompanying price spikes by making quality generic medicines accessible and affordable to everyone. In its capacity as the exclusive distributor, Cencora ensures that Civica’s products reach its members across the country efficiently, reliably, and securely. This partnership accelerates both companies’ mutual efforts to stabilize the supply of essential generic medicines nationwide.
US capitol color

Federal government

US capitol color

Public-private will continue to be essential in responding to drug shortages, and we encourage the federal government to better support and invest in promoting and advancing these partnerships with the private sector.

During the COVID-19 pandemic, public-private partnerships with the U.S. federal government, with agencies such as the FDA, FEMA, ASPR, HHS, as well as with state governments were incredibly helpful to meet shifting demands, mitigate supply chain disruptions and avoid shortages. 

US capitol color

Healthcare Ready

Through a longstanding partnership with Healthcare Ready – a nonprofit that brings together government, nonprofit and medical supply chains to build and enhance the resiliency of communities before, during and after disasters — we work to ensure sites of care in communities impacted by natural disasters continue to maintain access to the pharmaceuticals and medical supplies they need.

A recent study by Healthcare Ready — and funded by the Cencora Impact Foundation — examines the current landscape surrounding U.S. state medication stockpiles, which can help protect communities by providing a means of ensuring rapid access to essential medications during an emergency event. Access the full report here.

Responding to natural disasters

We have a proven track record of serving customers through natural disasters and extreme weather events — such as hurricanes, wildfires and flooding.

In those situations, we work closely with manufacturers, providers, government entities, and nonprofits, and leverage our vast distribution network and robust continuity planning to mitigate disruptions to the supply chain.  

Explore more resources

biopharma

Addressing medication shortages

SpltyDstBrooksBoxMaking117013

Pharmaceutical distribution solutions

We are united in our responsibility to create healthier futures

Through our businesses, we are well-positioned to understand the complexity of the pharmaceutical supply chain, the drivers and impacts of disruptions to the supply chain, and the solutions — including policy – needed to prevent shortages.